Description
Confirmed benefit of blinatumomab in difficult to treat patients with acute lymphoblastic leukemia
Article: Confirmed benefit of blinatumomab in difficult to treat patients with acute lymphoblastic leukemia
€3.03
€3.03
Confirmed benefit of blinatumomab in difficult to treat patients with acute lymphoblastic leukemia
You must be logged in to post a review.
Top
Reviews
There are no reviews yet.